Supplier

Gilead Sciences s.r.o.

Value won

CZK 181.1m

Across 2 contracts won

A Czech Republic supplier, with 2 awarded contracts, most recently 6 months ago.

Czech Republic(inferred)

Value won

CZK 181.1m

Across 2 contracts won

Contract history

2 entries

Most recent
11 Feb 2026
6 months ago
Biggest
CZK 164.8m
Supply of Cancer Treatment Drug for…
Average size
CZK 90.6m
Across 2 priced
Last 12 months
2
entries

Won · 2

Supply of Cancer Treatment Drug for Autologous Cell TherapyCZK 164,800,000 · 11 Feb 2026 Supply of SELADELPAR for Health ServicesCZK 16,328,876 · 7 Dec 2025

Nov 25Dec 25Jan 26Feb 26Feb 26

Opportunities

Showing awarded · 2

AwardedHealthcare & MedicalCzech Republic

Supply of Cancer Treatment Drug for Autologous Cell Therapy

This public procurement contract involves the supply of a cancer treatment drug intended for the therapy of malignant blood diseases. The total expected volume is 32 individual doses of the drug. This medication will be used in healthcare services at the FN Plzeň medical facility. Deliveries will be

CZK 164,800,000FACULTY HOSPITAL PILSEN

Published 11 Feb 2026

AwardedHealthcare & MedicalCzech Republic

Supply of SELADELPAR for Health Services

This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient A05AX07 SELADELPAR for a duration of 4 years. The contract is valued at approximately 16,328,875.68 EUR and is intended for health services. Suppliers interested in this opportunity ca

CZK 16,328,876UNIVERSITY HOSPITAL ST ANNE IN BRNO

Published 7 Dec 2025